Header Logo

Connection

Karen Wozniak to Cryptococcus neoformans

Back to Details
This is a "connection" page, showing publications Karen Wozniak has written about Cryptococcus neoformans.
Karen Wozniak
Connection Strength
8.008
Cryptococcus neoformans
  1. Effects of novel organoantimony compounds on the fungal pathogen Cryptococcus neoformans. J Med Microbiol. 2025 Sep; 74(9).
    View in: PubMed
    Score: 0.937
  2. Protective interaction of human phagocytic APC subsets with Cryptococcus neoformans induces genes associated with metabolism and antigen presentation. Front Immunol. 2022; 13:1054477.
    View in: PubMed
    Score: 0.772
  3. Transcriptional Changes in Pulmonary Phagocyte Subsets Dictate the Outcome Following Interaction With The Fungal Pathogen Cryptococcus neoformans. Front Immunol. 2021; 12:722500.
    View in: PubMed
    Score: 0.714
  4. Antifungal activity of dendritic cell lysosomal proteins against Cryptococcus neoformans. Sci Rep. 2021 06 30; 11(1):13619.
    View in: PubMed
    Score: 0.702
  5. Pulmonary Macrophage and Dendritic Cell Responses to Cryptococcus neoformans. Front Cell Infect Microbiol. 2020; 10:37.
    View in: PubMed
    Score: 0.638
  6. Molecules at the interface of Cryptococcus and the host that determine disease susceptibility. Fungal Genet Biol. 2015 May; 78:87-92.
    View in: PubMed
    Score: 0.442
  7. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection. Microbiology (Reading). 2014 Jul; 160(Pt 7):1440-1452.
    View in: PubMed
    Score: 0.426
  8. Mechanisms of dendritic cell lysosomal killing of Cryptococcus. Sci Rep. 2012; 2:739.
    View in: PubMed
    Score: 0.384
  9. Induction of protective immunity against cryptococcosis. Mycopathologia. 2012 Jun; 173(5-6):387-94.
    View in: PubMed
    Score: 0.362
  10. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vaccine Immunol. 2011 May; 18(5):717-23.
    View in: PubMed
    Score: 0.345
  11. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One. 2011 Feb 17; 6(2):e17204.
    View in: PubMed
    Score: 0.342
  12. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One. 2009 Sep 03; 4(9):e6854.
    View in: PubMed
    Score: 0.309
  13. Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect Immun. 2008 Oct; 76(10):4764-71.
    View in: PubMed
    Score: 0.287
  14. In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis. Infect Immun. 2006 Jul; 74(7):3817-24.
    View in: PubMed
    Score: 0.248
  15. IFN-? immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans. PLoS Pathog. 2018 10; 14(10):e1007358.
    View in: PubMed
    Score: 0.145
  16. Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection. PLoS One. 2017; 12(1):e0169347.
    View in: PubMed
    Score: 0.129
  17. Antifungal Activity of Plasmacytoid Dendritic Cells against Cryptococcus neoformans In Vitro Requires Expression of Dectin-3 (CLEC4D) and Reactive Oxygen Species. Infect Immun. 2016 09; 84(9):2493-504.
    View in: PubMed
    Score: 0.125
  18. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants. mBio. 2015 Oct 06; 6(5):e01433-15.
    View in: PubMed
    Score: 0.118
  19. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans. Infect Immun. 2015 Dec; 83(12):4513-27.
    View in: PubMed
    Score: 0.117
  20. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice. J Immunol. 2014 Oct 15; 193(8):4060-71.
    View in: PubMed
    Score: 0.109
  21. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by ?d T cells. BMC Immunol. 2012 Dec 07; 13:65.
    View in: PubMed
    Score: 0.097
  22. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection. Infect Immun. 2010 Dec; 78(12):5341-51.
    View in: PubMed
    Score: 0.083
  23. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am J Pathol. 2010 Feb; 176(2):774-85.
    View in: PubMed
    Score: 0.079
  24. Isolation and purification of antigenic components of Cryptococcus. Methods Mol Biol. 2009; 470:71-83.
    View in: PubMed
    Score: 0.074
  25. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J Immunol. 2012 Oct 15; 189(8):4060-8.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.